Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Co-pay coupons lifted Lipitor. Can they defend Diovan?
Fierce Pharma
Tuesday, August 21, 2012 - 5:10pm
tags:
co-pay coupons, Lipitor, Pfizer, Diovan, Novartis, Plavix, Bristol-Myers Squibb
Astex Climbs On Expected European Approval
Bloomberg
Tuesday, August 21, 2012 - 5:07pm
tags:
Astex, Europe
J&J unit recalls bone putty
Reuters
Tuesday, August 21, 2012 - 5:06pm
tags:
JNJ, recall, bone putty, Synthes
Pfizer-AstraZeneca’s Nexium Deal. Win-Win for both Companies?
Motley Fool
Tuesday, August 21, 2012 - 5:05pm
tags:
Pfizer, AstraZeneca, Nexium
NPS Pharma says FDA advisors will review the company's bowel drug Gattex
Yahoo/AP
Tuesday, August 21, 2012 - 12:20pm
tags:
FDA, NPS Pharmaceuticals, Gattex, short bowel syndrome
Spectrum Pharma Slashes Fusilev Price to Woo Doctors
TheStreet.com
Tuesday, August 21, 2012 - 12:11pm
tags:
Fusilev, drug pricing, Spectrum Pharmaceuticals, colon cancer
Sanofi pulls leukemia drug ahead of possible OK for Lemtrada
Reuters
Tuesday, August 21, 2012 - 12:10pm
tags:
Sanofi, Lemtrada, Campath, leukemia
Blood-thinner Pradaxa target of mass-claims suit
USA Today
Tuesday, August 21, 2012 - 12:09pm
tags:
Boehringer Ingelheim, bloodthinners, Pradaxa, lawsuits
Allergan adds $1.5B R&D pact as it builds ophthalmology pipeline
Fierce Biotech
Tuesday, August 21, 2012 - 12:07pm
tags:
Allergan, ophthalmology, Molecular Partners
Hirbe Powers: Extreme Bristol-Myers Rep Trainer
Pharmalot
Tuesday, August 21, 2012 - 12:05pm
tags:
drug reps, training, Bristol-Myers Squibb, Avalide, Avapro
Amarin: Update On NCE Status And Patent Protection
Seeking Alpha
Tuesday, August 21, 2012 - 12:03pm
tags:
patents, Amarin, Vascepa, GSK, Abbott Laboratories
Pfizer’s Experimental Arthritis Pill Delayed By 3 Months
Bloomberg
Tuesday, August 21, 2012 - 11:56am
tags:
Pfizer, FDA, tofacitinib, rheumatoid arthritis
Myriad Wins Patent Ruling Again
Yahoo/Zacks
Tuesday, August 21, 2012 - 11:40am
tags:
Myriad Genetics, patents, breast cancer, ovarian cancer, Bracanalysis
Stem Cell Therapy Outlook Starting To Match Clinical Results
Seeking Alpha
Tuesday, August 21, 2012 - 11:38am
tags:
Aastrom Biosciences, Baxter International, NeoStem, Osiris, Pluristem, AMR-101
3 High-Growth Biotech Stocks With Encouraging Inventory Trends
Seeking Alpha
Tuesday, August 21, 2012 - 11:33am
tags:
Biomarin, China Biologic, Anika
ImmunoCellular CEO Steps Down But Leaves Company Well Positioned
Seeking Alpha
Tuesday, August 21, 2012 - 11:32am
tags:
ImmunoCellular Therapeutics, Dendreon, Jazz Pharmaceuticals, Merck, Verastem, Roche, Oncothyreon
The Potential Market For Arena's Belviq
Seeking Alpha
Tuesday, August 21, 2012 - 11:30am
tags:
Arena Pharmaceuticals, Belviq, obesity
Novo Nordisk CFO Explains Winning Diabetes Strategy
Investors.com
Tuesday, August 21, 2012 - 11:11am
tags:
diabetes, Novo Nordisk
Synthes Investor Suits Over J&J Takeover Dismissed
Bloomberg
Tuesday, August 21, 2012 - 11:11am
tags:
JNJ, Synthes, M&A
Johnson & Johnson: The Doom And Gloom Crowd Is Wrong
Seeking Alpha
Monday, August 20, 2012 - 12:18pm
tags:
JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.